EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cancer: A bioelectric disease?

Celine Desoyer iD, Roko Šupe, Sahar Ghorbanpour iD, Debkalpa Goswami iD, Mina Khalaj iD, Nazanin Karami iD, Dagmar Brislinger iD, Charlotte A E Hauser iD, Christian Baumgartner iD

Clinical and Translational Medicine · 2026-05 · 16 (5)

DOI: 10.1002/ctm2.70701 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 21.05.2026. Verfasst von Celine Desoyer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Care Engineering with European Testing Center of Medical Devices, Graz University of Technology, Graz, Austria. Hauptthemen laut MEDLINE: Neoplasms, Membrane Potentials. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TU Graz Open Access Publishing Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer progression is driven by coordinated alterations in signalling networks that regulate proliferation, plasticity, metabolism and therapeutic response. Although genetic and epigenetic mechanisms are well characterised, there is an increasing body of evidence that suggests bioelectric signalling constitutes an additional integrative regulatory layer in tumour biology. In diverse experimental systems, malignant cells consistently exhibit depolarised transmembrane potentials ( V m ), which correlate with proliferation, stemness, invasion and therapy resistance, suggesting depolarisation as a conserved bioelectric hallmark of malignancy. This shifts the central question from whether cancer can be considered a bioelectric disease to the extent to which bioelectric signalling constitutes a relevant organising dimension of tumour biology. However, a quantitative, translationally actionable framework for membrane potential in cancer is lacking. Existing studies and reviews have largely focused on individual ion channels, specific tumour contexts, or conceptual aspects of bioelectricity without systematically establishing V m as a cross‐tumour, systems‐level state variable. Here, we summarise approximately 15 years of experimental and translational research to evaluate the extent to which V m functions as an integrative regulatory dimension of malignancy. Here, we define a state variable as a measurable, dynamically tuneable parameter that integrates multiple regulatory inputs and predicts system‐level cellular behaviour. At the same time, we identify key limitations in the current evidence base, including limited quantitative comparability across tumour types, incomplete mechanistic integration across regulatory layers, insufficient resolution of tumour heterogeneity and a lack of standardisation for clinical translation. Based on this review, we introduce a quantitative framework and a structured translational roadmap for incorporating bioelectric state control into precision oncology. This establishes membrane potential as not only a supplementary biomarker, but also a functional pharmacodynamic indicator and an actionable control variable for state‐guided therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMembrane PotentialsHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

bioelectric biomarkersbioelectric signallingcancer bioelectricityion channels in cancermembrane potential (Vm)precision oncologytumour progression and stemnesstumour‐treating fields

Autor:innen und Institutionen

  • Institute of Health Care Engineering with European Testing Center of Medical Devices, Graz University of Technology, Graz, Austria.
  • Department of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria.
  • BioTechMed Graz, Graz, Austria.
  • Laboratory for Nanomedicine, Division of Biological and Environmental Science and Engineering (BESE) and Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology, Thuwal, Kingd…

ORCID-Profile: Celine Desoyer, Sahar Ghorbanpour, Debkalpa Goswami, Mina Khalaj, Nazanin Karami, Dagmar Brislinger, Charlotte A E Hauser, Christian Baumgartner

Förderung

  • TU Graz Open Access Publishing Fund

Zitieren

APA

Desoyer, C., Šupe, R., Ghorbanpour, S., Goswami, D., Khalaj, M., Karami, N., Brislinger, D., Hauser, C. A. E., & Baumgartner, C. (2026). Cancer: A bioelectric disease?. Clinical and Translational Medicine, 16(5). https://doi.org/10.1002/ctm2.70701

Vancouver

Desoyer C, Šupe R, Ghorbanpour S, Goswami D, Khalaj M, Karami N, et al. Cancer: A bioelectric disease?. Clinical and Translational Medicine. 2026;16(5). doi:10.1002/ctm2.70701

BibTeX
@article{Desoyer2026,
  author = {Desoyer, Celine and Šupe, Roko and Ghorbanpour, Sahar and Goswami, Debkalpa and Khalaj, Mina and Karami, Nazanin and Brislinger, Dagmar and Hauser, Charlotte A E and Baumgartner, Christian},
  title = {Cancer: A bioelectric disease?},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  volume = {16},
  number = {5},
  doi = {10.1002/ctm2.70701}
}
Kostenlos starten →